Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06799962 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AI and VR Devices for Eating Behavior Rehabilitation

Study acronym: ARCADIA-VR
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 30, 2025 (before its estimated July 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Notable Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  2. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Eating disorders (ED) affect the relationship with food and body image. Virtual reality (VR), combined with artificial intelligence (AI), offers new clinical solutions, overcoming traditional cognitive behavioral therapy (CBT). The ARCADIA VR project aims to develop devices to treat ED through personalized VR systems (e.g. Enhanced Body-Swap for anorexia, Emotional Rescripting for bulimia) and AI predictive algorithms to monitor severity, risk and efficacy of treatments. These approaches promise better and faster results, improving diagnosis and treatment.
Trial Details
NCT Number NCT06799962
Lead Sponsor Istituto per la Ricerca e l'Innovazione Biomedica
Collaborators: Madre Teresa s.r.l, Medilink s.r.l., SB SETEC S.p.A, Catholic University of the Sacred Heart
Conditions
(from sponsor)
Eating Disorders, Anorexia Nervosa, Bulimia Nervosa
Related terms Anorexia Nervosa, Bulimia Nervosa, Emotional Regulation, Feeding and Eating Disorders
Enrollment 80 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov